Stay updated on Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial
Sign up to get notified when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.

Latest updates to the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page
- Check6 days agoChange DetectedThe page history now includes a new Revision: v3.3.2 entry and appears to remove the previous Revision: v3.3.1 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedFooter revision label updated from v3.2.0 to v3.3.1 to reflect the latest revision. No study data, navigation, or page functionality are affected.SummaryDifference0.1%

- Check20 days agoChange DetectedThe government funding/operating status notice at the bottom of the page was removed. This administrative change does not alter the study information or how users interact with the record.SummaryDifference0.5%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedDifference0.1%

- Check63 days agoChange DetectedUpdated operating status notice and newer versioning information; removed previous revision/date, indicating a shift to current status and version v3.2.0.SummaryDifference11%

- Check70 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.2%

Stay in the know with updates to Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.